tiprankstipranks
Egetis Therapeutics AB (SE:EGTX)
FRANKFURT:EGTX
Sweden Market
EGTX
Egetis Therapeutics AB
RESEARCH TOOLSreports

Egetis Therapeutics AB (EGTX) Financial Statements

― Followers

Egetis Therapeutics AB Financial Overview

Egetis Therapeutics AB's market cap is currently kr2.37B. The company's EPS TTM is kr-0.302; its P/E ratio is -5.74; Egetis Therapeutics AB is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is kr-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 62.40Mkr 46.10Mkr 57.60Mkr 22.50Mkr 38.24M
Gross Profitkr 12.40Mkr 34.50Mkr -146.90Mkr -120.10Mkr -58.28M
Operating Incomekr -346.90Mkr -329.40Mkr -324.80Mkr -198.10Mkr -105.68M
EBITDAkr -346.90Mkr -317.40Mkr -319.10Mkr -191.00Mkr -101.90M
Net Incomekr -342.50Mkr -343.60Mkr -326.90Mkr -189.50Mkr -104.73M
Balance Sheet
Cash & Short-Term Investmentskr 215.80Mkr 351.00Mkr 303.30Mkr 127.70Mkr 143.97M
Total Assetskr 639.10Mkr 792.30Mkr 760.20Mkr 561.10Mkr 569.27M
Total Debtkr 76.50Mkr 117.40Mkr 113.00Mkr 2.70Mkr 4.20M
Net Debtkr -139.30Mkr -233.60Mkr -190.30Mkr -125.00Mkr -139.76M
Total Liabilitieskr 300.40Mkr 299.40Mkr 214.60Mkr 54.90Mkr 42.23M
Stockholders' Equitykr 338.70Mkr 492.80Mkr 545.60Mkr 506.20Mkr 527.04M
Cash Flow
Free Cash Flowkr -268.60Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.28M
Operating Cash Flowkr -267.10Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.11M
Investing Cash Flowkr -2.80Mkr -1.20Mkr -100.00Kkr -1.70Mkr -5.96M
Financing Cash Flowkr 140.00Mkr 270.90Mkr 458.90Mkr 155.70Mkr -8.90M
Currency in SEK

Egetis Therapeutics AB Earnings and Revenue History

Income Statement >

Egetis Therapeutics AB Debt to Assets

Balance Sheet >

Egetis Therapeutics AB Cash Flow

Cash Flow >

Egetis Therapeutics AB Forecast EPS vs Actual EPS

Earnings >